Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO Katharina Jünger

Munich, 28 March 2022. Katharina Jünger, the founder and CEO of TeleClinic GmbH, is leaving the company at her own request with effect from 1 April 2022 to take on new professional challenges following her parental leave. Long-standing co-managing director Max Müller will take on her tasks and responsibilities. Together, the two made TeleClinic what it is today – the leading telemedicine platform in Germany.

Since 2015, Katharina Jünger has built up TeleClinic into the leading platform for online doctor’s consultations in Germany. Following the change of ownership in July 2020, she managed the successful integration of TeleClinic into the Zur Rose Group. Thanks to its high quality standards, TeleClinic has now secured its position with doctors and patients as the first port of call for digital healthcare. Every month, doctors registered in Germany treat tens of thousands of patients and the company remains on the growth track. Under the leadership double act to date, TeleClinic has played a major role in shaping the digital healthcare market in Germany. During the coronavirus pandemic in particular, telemedicine made an important contribution to providing healthcare across the country. Patients can consult a doctor online by video and be given prescriptions and sick notes.

Walter Hess, Head Germany at the Zur Rose Group, said: “Katharina Jünger has shown great dedication and personal commitment in building TeleClinic up to be a pioneer and leading provider of telemedical services in Germany, actively driving ahead the digitalisation of the healthcare system. On behalf of the Management Board I would like to thank her for the successful time we have spent together and wish her every success and all the best personally in her ambition to set up many more strong companies.” 

Katharina Jünger will be succeeded by Max Müller. As co-managing director and COO of TeleClinic, Max Müller is very familiar with the operating telemedicine business, the company’s strategic projects and the opportunities and challenges arising from digitalisation in Germany. Walter Hess added: “As COO, Max Müller built TeleClinic up into a rapidly growing provider of telemedicine. He has deep marketing and product expertise and as the new CEO he will lead TeleClinic into the next phase of its development within the Zur Rose Group.”

About TeleClinic:

TeleClinic GmbH is the German leader in online doctor’s consultations. Since July 2020 the platform provider has belonged to Zur Rose Group AG, Europe’s largest e-commerce pharmacy. Using the TeleClinic app, in just a few hours patients receive telemedical treatment from an experienced doctor registered in Germany. Sick notes, prescriptions and doctor’s letters are sent straight to the patient’s smartphone. Prescriptions can be filled all over the country in one of some 18,500 local pharmacies or by an online provider. Since December 2020 doctors have also been able to prescribe certified digital healthcare applications (DiGa) by video consultation.

For more information go to www.teleclinic.com

Press contact TeleClinic:      
Torben Bonnke
Director Communication & PR
Zur Rose Group, Segment Germany
info@teleclinic.com
Mobile: +49  171 864 888 1